Erste Asset Management GmbH »

Abcellera Biologics shares owned by Erste Asset Management GmbH

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Erste Asset Management GmbH from 13F filings

Historical chart of Erste Asset Management GmbH investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Erste Asset Management GmbH consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Erste Asset Management GmbH

Quarter filed Position value Share count Share price at filing
2024-09-30 $162k 62k 2.61
2024-06-30 $179k 62k 2.88
2024-03-31 $278k 62k 4.49
2023-12-31 $368k 62k 5.93
2023-09-30 $289k 62k 4.66
2023-06-30 $408k 62k 6.58
2023-03-31 $460k 62k 7.42
2022-12-31 $623k 62k 10.05
2022-09-30 $611k 62k 9.85
2022-06-30 $627k 62k 10.11
2022-03-31 $605k 62k 9.75

More positions owned by Erste Asset Management GmbH

Nvidia Corporation Common Stock (NVDA)
Microsoft Corporation Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
Meta Platforms Common Stock (META)
Unitedhealth Group Incorporated Common Stock (UNH)
Netflix Common Stock (NFLX)
Visa Common Stock (V)
Adobe Common Stock (ADBE)
The Progressive Corporation Common Stock (PGR)
Broadcom Common Stock (AVGO)
Agios Pharmaceuticals Common Stock (AGIO)
Lam Research Corporation Common Stock (LRCX)
Kla Corporation Common Stock (KLAC)
Amazon.com Common Stock (AMZN)

View all positions for Erste Asset Management GmbH

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
BlackRock
Renaissance Technologies
Tang Capital Management
Federated Investors
Two Sigma Investments
Guardian Capital Advisors
Two Sigma Advisers
Citadel Advisors
Novo A/S

View all funds holding Abcellera Biologics